A Phase 1a, Repeat-Dose Escalation Study to Investigate the Safety and Tolerability of a 7-Day Repeated Dose of Retinoid QLT091001 in Healthy Volunteers

Trial Profile

A Phase 1a, Repeat-Dose Escalation Study to Investigate the Safety and Tolerability of a 7-Day Repeated Dose of Retinoid QLT091001 in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Dec 2013

At a glance

  • Drugs Zuretinol acetate (Primary)
  • Indications Age-related macular degeneration; Leber congenital amaurosis; Retinitis pigmentosa
  • Focus Adverse reactions
  • Sponsors QLT
  • Most Recent Events

    • 04 Dec 2013 New trial record
    • 28 Mar 2009 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top